Aytu BioScience Downside Variance

AYTU Stock  USD 2.50  0.03  1.21%   
Downside Variance (or DV) is measured by target semi-variance and is termed downside volatility. It is expressed in percentages and therefore allows for rankings in the same way as variance. One way to view downside volatility is the annualized variance of returns below the target. Below is Aytu BioScience's current Downside Variance with peer comparisons and related risk metrics.

Current Downside Variance Value

Aytu BioScience carries a Downside Variance of 5.29, consistent with elevated price variability. This places Aytu BioScience toward the higher end of the volatility range for Pharmaceuticals.

Downside Variance

 = 

SUM(RET DEV)2

N(ER)

 = 
5.29
SUM = Summation notation
RET DEV = Actual returns deviation over selected period
N(ER) = Number of points with returns less than expected return for the period

Downside Variance Peers Comparison

Among sector peers, Aytu BioScience's Downside Variance of 5.29 is below the 80.33 group average. The range runs from 9.62 (Biofrontera) to 179.33 (Allurion Technologies). Aytu BioScience has exhibited less price dispersion than the peer average over the measured period.

Downside Variance Relative To Other Indicators

The chart below plots Downside Variance against Maximum Drawdown for Aytu BioScience and its peers. Each point represents one equity — position along the horizontal axis shows Downside Variance while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Comparing Downside Variance ( 5.29 ) to Maximum Drawdown ( 10.28 ) for Aytu BioScience yields a 1.94 multiple. This indicates Maximum Drawdown moderately exceeds Downside Variance for Aytu BioScience.
Compare Aytu BioScience to Peers

Methodology, Assumptions & Data Sources

Aytu BioScience has a current Downside Variance reading of 5.29. The Downside Variance for Aytu BioScience is produced by transforming raw price history into a standardized measure according to the indicator's defined methodology. Data sources include daily closing prices from supported exchanges, with standard corporate action adjustments applied. Aytu BioScience operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. The output reflects the selected calculation window — changing the horizon will produce different readings. This stock metric is provided for analytical reference.

Other Technical Indicators